Mei Guo

87 Ding Jiaqiao Rd
Nanjing, 210009, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 32 publications

METTL3/FTO drives ferroptosis in colorectal cancer by targeting m6A modification of MUC1 mRNA and YTHDF2-dependent SLC7A11/GSH pathway.

METTL3/FTO drives ferroptosis in colorectal cancer by targeting m6A modification of MUC1 mRNA and YTHDF2-dependent SLC7A11/GSH pathway.

Journal: Journal of gastroenterology

Published: January 19, 2026

YTHDF2-orchestrated m6A methylation of BECN1 induces Scoparone-mediated hepatic stellate cell ferroptosis to attenuate liver fibrosis.

YTHDF2-orchestrated m6A methylation of BECN1 induces Scoparone-mediated hepatic stellate cell ferroptosis to attenuate liver fibrosis.

Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology

Published: November 12, 2025

Editorial: Advances in targeted therapy and biomarker research for endocrine-related cancers, volume II.

Editorial: Advances in targeted therapy and biomarker research for endocrine-related cancers, volume II.

Journal: Frontiers in endocrinology

Published: October 31, 2025

Artemether relieves liver fibrosis by triggering ferroptosis in hepatic stellate cells via DHHC12-mediated S-palmitoylation of the BECN1 protein.

Artemether relieves liver fibrosis by triggering ferroptosis in hepatic stellate cells via DHHC12-mediated S-palmitoylation of the BECN1 protein.

Journal: Free radical biology & medicine

Published: January 07, 2025

The m6A modification in cancer: roles, implications, and its potential in therapy.

The m6A modification in cancer: roles, implications, and its potential in therapy.

Journal: Molecular biomedicine

Published: November 27, 2024

Elafibranor alleviates alcohol-related liver fibrosis by restoring intestinal barrier function.

Elafibranor alleviates alcohol-related liver fibrosis by restoring intestinal barrier function.

Journal: World journal of gastroenterology

Published: July 26, 2024

Advances in targeted therapy and biomarker research in thyroid cancer.

Advances in targeted therapy and biomarker research in thyroid cancer.

Journal: Frontiers in endocrinology

Published: January 18, 2024

The cell fate regulator DACH1 modulates ferroptosis through affecting P53/SLC25A37 signaling in fibrotic disease.

The cell fate regulator DACH1 modulates ferroptosis through affecting P53/SLC25A37 signaling in fibrotic disease.

Journal: Hepatology communications

Published: October 24, 2023

COVID-19-associated liver injury: Adding fuel to the flame.

COVID-19-associated liver injury: Adding fuel to the flame.

Journal: Cell biochemistry and function

Published: August 23, 2023

Autophagy activation is required for N6-methyladenosine modification to regulate ferroptosis in hepatocellular carcinoma.

Autophagy activation is required for N6-methyladenosine modification to regulate ferroptosis in hepatocellular carcinoma.

Journal: Redox biology

Published: July 18, 2023

Artesunate Induces Ferroptosis in Hepatic Stellate Cells and Alleviates Liver Fibrosis via the ROCK1/ATF3 Axis.

Artesunate Induces Ferroptosis in Hepatic Stellate Cells and Alleviates Liver Fibrosis via the ROCK1/ATF3 Axis.

Journal: Journal of clinical and translational hepatology

Published: April 09, 2023

Targeting pancreatic stellate cells in chronic pancreatitis: Focus on therapeutic drugs and natural compounds.

Targeting pancreatic stellate cells in chronic pancreatitis: Focus on therapeutic drugs and natural compounds.

Journal: Frontiers in pharmacology

Published: September 12, 2022

Showing 1-12 of 32

Last Updated: 09/26/2026